{"result": "(\"entity\"<|>GALACTOSEMIA<|>EVENT<|>Galactosemia is a metabolic disorder that affects the body's ability to process galactose, leading to dietary restrictions and health monitoring.)\n##\n(\"entity\"<|>SOJA<|>ORGANIZATION<|>Soja refers to soy-based formulas recommended for infants with galactosemia as a substitute for dairy products.)\n##\n(\"entity\"<|>ALIMENTOS<|>ORGANIZATION<|>Alimentos refers to various food items that may contain galactose and are subject to dietary restrictions for individuals with galactosemia.)\n##\n(\"entity\"<|>CALCIO<|>PERSON<|>Calcium is a vital nutrient that must be ensured in the diet of individuals with galactosemia, especially during lactation.)\n##\n(\"entity\"<|>VITAMINA D<|>PERSON<|>Vitamin D is another essential nutrient that needs to be provided through soy formulas for infants with galactosemia.)\n##\n(\"relationship\"<|>GALACTOSEMIA<|>SOJA<|>Soy formulas are recommended for individuals with galactosemia to avoid dairy products that contain galactose.<|>8)\n##\n(\"relationship\"<|>GALACTOSEMIA<|>ALIMENTOS<|>Certain foods are restricted in the diet of individuals with galactosemia due to their galactose content.<|>7)\n##\n(\"relationship\"<|>GALACTOSEMIA<|>CALCIO<|>Calcium intake is crucial for individuals with galactosemia, especially during lactation, to ensure proper nutrition.<|>6)\n##\n(\"relationship\"<|>GALACTOSEMIA<|>VITAMINA D<|>Vitamin D is necessary for individuals with galactosemia to maintain health, particularly in infants on soy formulas.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: realizará\n       mayor que la ingerida en la dieta; además, la apa-                   de forma similar a la variante Duarte (D/G).\n       rición de complicaciones tardías no se modifican\n       con el tratamiento dietético y el período de riesgo             2.2.3.    Recomendaciones dietéticas\n       de complicaciones agudas ya ha pasado. Por el\n       momento, hasta que exista mayor evidencia cien-                   En los pacientes con galactosemia los requerimien-\n       tífica, se recomienda de forma unánime evitar los               tos calóricos, proteicos y de vitaminas y otros micronu-\n       productos lácteos de por vida. Con respecto a los               trientes son similares a los de la población general, se-\n       alimentos no lácteos que contienen galactosa no                 gún edad y sexo.\n       existe consenso, pero probablemente lo prudente                   La principal fuente de galactosa es la leche, por lo\n       en niños mayores y adultos sea evitar su abuso, sin             que debe evitarse en todas sus formas, así como los\n       excluirlos por completo.                                        derivados lácteos.\n       Se pueden monitorizar los niveles de Gal-1-P eri-                 En los lactantes hay que suspender la lactancia ma-\n       trocitaria y el cociente galactitol urinario/creatini-          terna ante la primera sospecha clínica y evitar cualquier\n       na urinaria periódicamente para detectar trans-                 fórmula que contenga lactosa. Se recomiendan las fór-\n       gresiones     dietéticas.    Se   considera      como     buen  mulas a base de soja, y deben evitarse las fórmulas de-\n       cumplimiento terapéutico los valores de Gluc-1-P                nominadas «sin lactosa» con hidrolizados de proteínas\n       < 5 mg/dl y de Galactitol urinario < 78 mmol/                   de leche de vaca, ya que pueden contener lactosa jun-\n       mol. Hay que tener en cuenta que la Gal-1-P sólo                to a la caseína y seroalbúmina utilizadas. Aunque no se\n       refleja  la   ingesta    de   galactosa      en   las  últimas  ha demostrado que sean perjudiciales por falta de en-\n       24 horas y en cambio el galactitol aumenta por                  sayos clínicos randomizados, es preferible no utilizarlos\n       transgresiones mantenidas y no detecta las agu-                 por el riesgo potencial que conllevan.\n       das. También existe variabilidad intraindividual y                Además de los derivados lácteos existen otros ali-\n       además pueden producirse elevaciones debido a                   mentos no lácteos que también contienen galactosa,\n       la producción endógena de galactosa en pacien-                  como las legumbres, cereales, vísceras y algunas frutas\n       tes que cumplen bien la dieta.                                  y verduras (tabla 4). Sin embargo, como hemos dicho,\n       En aquellos casos en que se realiza un diagnóstico              la cantidad de galactosa que contienen estos alimentos\n       prenatal, la restricción de galactosa en la madre               y su disponibilidad es muy pequeña, mucho menor\n---\n                                      Tema 14.      Soporte nutricional en patologías con alteración en el procesamiento…                          227\n\n\n\nque la producción endógena de galactosa, por lo que                             (5-20 mg/100 g), y prohibidos               por ser muy ricos en\nestá en discusión si deben ser restringidos o no. En                            galactosa (>20 mg/100 g).\ncualquier caso, lo que sí está claro es que no deben                               Por otra parte, es preferible consumir carnes magras\nconsumirse en grandes cantidades, y no ingerir los que                          frescas, ya que la descomposición microbiana también\nsean fácilmente sustituibles en la dieta por otros de si-                       puede      liberar   galactosa.     También       son    una    posible\nmilar riqueza nutricional, ya que aunque probable-                              fuente de galactosa o lactosa los productos manufac-\nmente no sean perjudiciales, no vale la pena correr el                          turados y medicamentos, por lo que es fundamental\nriesgo. En la tabla 6 se resumen los alimentos prohibi-                         leer el etiquetado de los mismos.\ndos y permitidos en la galactosemia. Las guías los han                             Durante el período de lactancia el aporte de calcio y\ndividido en tres grupos: libre utilización por no conte-                        vitamina D está garantizado con las fórmulas de soja\nner prácticamente galactosa (< 5 mg/100 g), a consu-                            siempre      que    se   administre      un   volumen       suficiente,\nmir con prudencia           y realizando controles analíticos                   como ocurre en los primeros 6 meses de vida. Sin em-\n\n\n\nTabla 6.    Alimentos permitidos y prohibidos en la galactosemia.\n\n\n\n                                ·  Fórmulas de so\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}